Literature DB >> 21798671

Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis.

Patrizia Morbini1, Simona Inghilleri, Ilaria Campo, Tiberio Oggionni, Michele Zorzetto, Maurizio Luisetti.   

Abstract

The hypothesis that epithelial-mesenchymal transition (EMT) contributes to the formation of fibroblast foci (FF), which are the histological hallmark and the site of active disease progression of Idiopathic Pulmonary Fibrosis (IPF), has not yet received a conclusive demonstration. Cells undergoing EMT lose epithelial features and acquire mesenchymal markers and morphology. Cadherin expression switch (from E to N) is one of the first events in EMT. We investigated the immunohistochemical expression of E- and N-cadherin, vimentin, fibronectin, laminin-5-γ2, α-smooth muscle actin, and fibroblast-specific protein-1 involved in EMT in 20 IPF lung biopsies, focusing on metaplastic squamous cells of bronchial basal origin, positive for laminin-5-γ2 and ΔNp63/p40, that cover FF. The results were compared with organizing pneumonia, reactive squamous cell metaplasia of bronchiolar epithelia, and squamous cell carcinoma. Bronchiolar basal metaplastic cells in IPF partially lost E-cadherin and expressed vimentin and fibronectin. Hyperplastic pneumocytes in IPF and controls coexpressed E-cadherin and N-cadherin, and were weakly positive for lam5-γ2. Reactive squamous cell metaplasia did not show any mesenchymal markers. Squamous cell carcinoma only expressed lam5-γ2. In IPF lungs, we observed two epithelial cell populations with a different expression profile of markers involved in EMT. Although neither hyperplastic pneumocytes nor bronchial basal cells showed evidence of complete EMT, only the latter seem to be specific for UIP and might have a role in its development.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798671     DOI: 10.1016/j.prp.2011.06.006

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  19 in total

1.  Regulation of Collagen V Expression and Epithelial-Mesenchymal Transition by miR-185 and miR-186 during Idiopathic Pulmonary Fibrosis.

Authors:  Guang-Sheng Lei; Hannah L Kline; Chao-Hung Lee; David S Wilkes; Chen Zhang
Journal:  Am J Pathol       Date:  2016-07-05       Impact factor: 4.307

2.  Esophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transition.

Authors:  Amanda B Muir; Kara Dods; Yuli Noah; Sarit Toltzis; Prasanna Modayur Chandramouleeswaran; Anna Lee; Alain Benitez; Adam Bedenbaugh; Gary W Falk; Rebecca G Wells; Hiroshi Nakagawa; Mei-Lun Wang
Journal:  Exp Cell Res       Date:  2014-08-27       Impact factor: 3.905

3.  Bronchial epithelium epithelial-mesenchymal plasticity forms aberrant basaloid-like cells in vitro.

Authors:  Dinesh Babu Uthaya Kumar; Efthymios Motakis; Marina Yurieva; Vivek Kohar; Jan Martinek; Te-Chia Wu; Johad Khoury; Jessica Grassmann; Mingyang Lu; Karolina Palucka; Naftali Kaminski; Jonathan L Koff; Adam Williams
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-04-19       Impact factor: 6.011

4.  miR-184 targets TP63 to block idiopathic pulmonary fibrosis by inhibiting proliferation and epithelial-mesenchymal transition of airway epithelial cells.

Authors:  Jianmin Li; Chanyuan Pan; Chao Tang; Wenwen Tan; Weiwei Zhang; Jing Guan
Journal:  Lab Invest       Date:  2020-09-28       Impact factor: 5.662

5.  CXCL9 Regulates TGF-β1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells.

Authors:  Sarah L O'Beirne; Sinead M Walsh; Aurélie Fabre; Carlota Reviriego; Julie C Worrell; Ian P Counihan; Robert V Lumsden; Jennifer Cramton-Barnes; John A Belperio; Seamas C Donnelly; Denise Boylan; Joëlle Marchal-Sommé; Rosemary Kane; Michael P Keane
Journal:  J Immunol       Date:  2015-08-12       Impact factor: 5.422

6.  Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts.

Authors:  Na Tang; Yanxia Zhao; Ruopeng Feng; Yinan Liu; Shuling Wang; Wanguo Wei; Qiang Ding; Michael Songzhu An; Jinhua Wen; Lingsong Li
Journal:  J Cell Mol Med       Date:  2013-11-19       Impact factor: 5.310

7.  Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.

Authors:  H Liang; Y Gu; T Li; Y Zhang; L Huangfu; M Hu; D Zhao; Y Chen; S Liu; Y Dong; X Li; Y Lu; B Yang; H Shan
Journal:  Cell Death Dis       Date:  2014-05-22       Impact factor: 8.469

8.  A novel multikinase inhibitor SKLB-YTH-60 ameliorates inflammation and fibrosis in bleomycin-induced lung fibrosis mouse models.

Authors:  Hongyao Liu; Xiuli Wu; Cailing Gan; Liqun Wang; Guan Wang; Lin Yue; Zhihao Liu; Wei Wei; Xingping Su; Qianyu Zhang; Zui Tan; Yuqin Yao; Liang Ouyang; Luoting Yu; Tinghong Ye
Journal:  Cell Prolif       Date:  2021-06-14       Impact factor: 6.831

Review 9.  Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis.

Authors:  Mohit Kumar Jolly; Marcelo Boareto; Bin Huang; Dongya Jia; Mingyang Lu; Eshel Ben-Jacob; José N Onuchic; Herbert Levine
Journal:  Front Oncol       Date:  2015-07-20       Impact factor: 6.244

10.  Activation of oncogenic pathways in idiopathic pulmonary fibrosis.

Authors:  Giulia M Stella; Simona Inghilleri; Ymera Pignochino; Michele Zorzetto; Tiberio Oggionni; Patrizia Morbini; Maurizio Luisetti
Journal:  Transl Oncol       Date:  2014-06-14       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.